These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 17572252

  • 1. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T, Lieder F, Bartelsmeier M, Leuner C, Borchert B, Meyer zu Vilsendorf D, Strunk-Mueller C, Reinhardt J, Feuchtl A, Stellbrink C, Kuhn H.
    J Am Coll Cardiol; 2007 Jun 19; 49(24):2356-63. PubMed ID: 17572252
    [Abstract] [Full Text] [Related]

  • 2. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
    Gao YC, Li Y, Han ZH, Zhang XL, Zhao H, Jiang TY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr 19; 35(4):333-6. PubMed ID: 17711659
    [Abstract] [Full Text] [Related]

  • 3. Quantitative and qualitative changes in the resting electrocardiograph after percutaneous transluminal septal myocardial ablation for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.
    Thai WE, Antonis PR, Hope SA, Meredith IT.
    Heart Lung Circ; 2008 Oct 19; 17(5):364-9. PubMed ID: 18657474
    [Abstract] [Full Text] [Related]

  • 4. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H, Wang P, Xing Y, Peng F, Jiang J, Yang B, You B, Qiu Y, Lee JD.
    J Electrocardiol; 2007 Oct 19; 40(4):356.e1-6. PubMed ID: 17316677
    [Abstract] [Full Text] [Related]

  • 5. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T, Obergassel L, Lieder F, Leuner C, Strunk-Mueller C, Meyer Zu Vilsendorf D, Beer G, Kuhn H.
    Pacing Clin Electrophysiol; 2005 Apr 19; 28(4):295-300. PubMed ID: 15826262
    [Abstract] [Full Text] [Related]

  • 6. Ablation for atrioventricular nodal reentrant tachycardia with a prolonged PR interval during sinus rhythm: the risk of delayed higher-degree atrioventricular block.
    Reithmann C, Remp T, Oversohl N, Steinbeck G.
    J Cardiovasc Electrophysiol; 2006 Sep 19; 17(9):973-9. PubMed ID: 16800857
    [Abstract] [Full Text] [Related]

  • 7. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
    Gietzen FH, Leuner CJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C, Kuhn HJ.
    Eur Heart J; 1999 Sep 19; 20(18):1342-54. PubMed ID: 10462469
    [Abstract] [Full Text] [Related]

  • 8. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F, Di Mario C, Catanoso A, Dharmadhikari A, Tzifos V, Anzuini A, Carlino M, Briguori C, Montorfano M, Vaghetti M, Tolaro S, Colombo A.
    Ital Heart J; 2000 Mar 19; 1(3):200-6. PubMed ID: 10806987
    [Abstract] [Full Text] [Related]

  • 9. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
    Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, Dearani JA, Schaff HV, Holmes DR.
    J Am Coll Cardiol; 2004 Dec 21; 44(12):2329-32. PubMed ID: 15607394
    [Abstract] [Full Text] [Related]

  • 10. [The effect on electrocardiographic and cardiac autonomic function after percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy].
    Xing YB, Guo HY, Wang P, You BQ, Chen JZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug 21; 35(8):731-4. PubMed ID: 17963633
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Chen AA, Palacios IF, Mela T, Yoerger DM, Picard MH, Vlahakes G, Lowry PA, Fifer MA.
    Am J Cardiol; 2006 Jan 15; 97(2):264-9. PubMed ID: 16442376
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Resolution of refractory ascites after transcoronary septal ablation for hypertrophic obstructive cardiomyopathy in a cirrhotic patient.
    Höblinger A, Tiemann K, Nickenig G, Sauerbruch T, Lammert F.
    Z Gastroenterol; 2008 Oct 15; 46(10):1194-7. PubMed ID: 18937189
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.